What is Pulmatrix Inc?
, a biopharmaceutical company, focused on development of novel inhaled therapeutic products to prevent and treat migraine and respiratory diseases with unmet medical needs in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a biopharmaceutical company, focused on development of novel inhaled therapeutic products to prevent and treat migraine and respiratory diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 4.71M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.